In conjunction with the financing, Techcyte gained access to a large dataset of slides and pathology reports from the Mayo Clinic.

The advanced diagnostics space was something of an exception, however, as these stakeholders signaled more openness to the idea, though not without reservations.

NEW YORK – The US Food and Drug Administration granted 510(k) clearances in March to a dozen in vitro diagnostic products from Qiagen, BioMérieux, Streck, Beckman Coulter, and others. The clearances ...

Comprising more than 20 firms and organizations across the infectious disease space, the compact will address issues like test access and data fragmentation.

Eand arlier this month, the CDC said it was temporarily pausing testing for a range of diseases including rabies, poxviruses, the Epstein-Barr virus.

Quest plans to use the net proceeds for general corporate purposes, which may include repaying debt such as $500 million in senior notes maturing on June 1.

MUNICH – When the decision was made to create and implement new regulations for in vitro diagnostics in the European Union several years ago, the intention was to improve testing accuracy and patient ...

NEW YORK – Germany's Wilhelm Sander Foundation said on Friday that it is granting approximately €1 million ($1.2 million) to a research team at Ludwig Maximilian University of Munich and the Max ...

The firm presented data at AACR this week showing the improved performance of its molecular pancreatic cancer early detection assay.

The tests use AI-powered algorithms to analyze digital histopathology images, along with patient clinical data.